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Abstract We investigated the role that mitochondrial proton
leak may play in the glucocorticoid-induced hypermetabolic
state. Sprague^Dawley rats were injected with dexamethasone
over a period of 5 days. Liver mitochondria and gastrocnemius
subsarcolemmal and intermyo¢brillar mitochondria were iso-
lated from dexamethasone-treated, pair-fed and control rats.
Respiration and membrane potential were measured simulta-
neously using electrodes sensitive to oxygen and to the poten-
tial-dependent probe triphenylmethylphosphonium, respectively.
Five days of dexamethasone injection resulted in a marked in-
crease in the basal proton conductance of liver mitochondria,
but not in the muscle mitochondrial populations. This e¡ect
would have a modest impact on energy expenditure in rats.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The development of the hypermetabolic state that is ob-
served following traumatic injury, sepsis or during surgical
stress may arise from increased plasma glucocorticoid hor-
mone levels [1]. This state is characterized by increased resting
energy expenditure, accelerated net protein breakdown, a neg-
ative nitrogen balance, increased gluconeogenesis, hyperglyce-
mia and insulin resistance [2]. Although the mechanisms in-
volved are incompletely understood, it is likely that several
cellular energy-demanding processes are responsible for the
raised resting energy expenditure. Indeed, glucocorticoids
have been well characterized to stimulate energy-demanding
pathways such as gluconeogenesis in the liver and kidney [3,4],
energy-ubiquitin-dependent muscle proteolysis [5,6] and en-
ergy-dependent glutamine synthetase activity in skeletal
muscle [7,8]. Collectively, these energy-dependent pathways
are likely to enhance ATP turnover in organs such as liver,
kidney and skeletal muscle, which would in turn contribute to
an increased whole body energy expenditure. However, not all
of the mammalian oxygen consumption is coupled to mito-
chondrial ATP synthesis, and the best estimates from all avail-
able data suggest that 20% of resting metabolic rate is due to
futile proton cycling across the the inner mitochondrial mem-
brane via endogenous proton conductance pathways [9].
These ‘proton leak’ reactions have been shown to account
for a high proportion of cellular resting metabolic rates in
hepatocytes (25% [10]) and in skeletal muscle (52% [11]),
two organs which together contribute nearly half of the oxy-
gen consumption of an adult rat. The early investigation of
Buttgereit et al. [12] on isolated rat thymocytes is the only
study which has provided evidence that glucocorticoids could
increase the rate of mitochondrial proton leak within cells.
However, the e¡ect of chronic infusion of glucocorticoids on
mitochondrial proton leak kinetics has not been addressed so
far.
In light of these observations, we wondered whether treat-
ment with dexamethasone a¡ects the cellular energy expendi-
ture of these organs, focusing on the mitochondrial proton
leak, which is the largest single contributor to cellular meta-
bolic rate in rats [9]. In the present study the e¡ect of dexa-
methasone administered to rats over 5 days on mitochondrial
proton leak kinetics was investigated in mitochondria isolated
from the liver and gastrocnemius muscle. One feature of skel-
etal muscle is that two mitochondrial populations (subsarco-
lemmal and intermyo¢brillar mitochondria) have been de¢ned
which di¡er in terms of their location, function, and response
to physiological stimuli [13^17]. Therefore, we also evaluated
the e¡ect of dexamethasone on the kinetics of proton leak of
these two mitochondrial populations isolated from rat gas-
trocnemius muscle.
2. Materials and methods
2.1. Animals and experimental design
The present investigation was performed in accordance with the
guiding principles in the care and use of animals. Male Sprague^
Dawley rats were caged individually in a temperature-controlled
room (22‡C) with a dark/light cycle of 12:12 h. They were maintained
on a standard rat chow diet consisting of 16% protein, 3% fat, 60%
carbohydrate, and 21% water, ¢ber, vitamins, and minerals (A04,
UAR, Ifacredo, L’Arbresle, France) and were allowed to drink water
ad libitum. Dexamethasone-treated rats were injected intraperito-
neally once daily with dexamethasone (1.5 mg/kg body weight) for
5 days and were allowed to feed ad libitum. The dexamethasone dose
(1.5 mg/kg/day) and the duration of treatment (5 days) were speci¢-
cally chosen as this treatment induced a reproducible and marked
catabolic state [8]. Control rats received no treatment and were fed
ad libitum. In order to take into account the decrease in food intake
induced by dexamethasone treatment, a third group of pair-fed rats
were used. These rats were provided with the same amount of food as
dexamethasone-injected rats and were treated with a daily isovolumic
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intraperitoneal injection of NaCl (0.9%) for 5 days. After the ¢nal
injection of dexamethasone or NaCl, the animals were fasted over-
night prior to being killed by decapitation.
2.2. Isolation of liver and skeletal muscle mitochondria
The liver and the gastrocnemius muscle were immediately dissected,
weighed and placed in ice-cold isolation medium containing 100 mM
sucrose, 50 mM KCl, 50 mM Tris^HCl, 5 mM EGTA, pH 7.4. Gas-
trocnemius muscle was chosen as this mixed ¢ber muscle is suitably
representative of the composition of all skeletal muscle ¢ber types
found in the adult Sprague^Dawley rat hindlimb [18]. Liver mitochon-
dria and gastrocnemius muscle intermyo¢brillar (IFM) and subsarco-
lemmal (SSM) mitochondria were isolated from two rats, the prepa-
rations of which are described by Krahenbuhl et al. [19] and Roussel
et al. [17] respectively, with all steps carried out at 4‡C. Liver and
muscles were chopped ¢nely with sharp scissors and homogenized
with a Potter-Elvehjem homogenizer (¢ve passages).
The liver homogenate was centrifuged at 600Ug for 10 min, and the
resulting supernatant was then ¢ltered through cheesecloth and cen-
trifuged at 7000Ug for 10 min. The pellet was resuspended in isola-
tion medium and centrifuged at 3500Ug for 10 min, and resuspended
in a minimal volume of isolation medium.
The muscle homogenate was centrifuged at 600Ug for 10 min. The
supernatant containing the SSM was centrifuged at 1000Ug for 10
min. The pellet containing the IFM was resuspended in 40 ml of
isolation medium and then treated with nagarse (1 mg/g muscle wet
weight) for 5 min in an ice bath. The mixture was diluted 1:2, ho-
mogenized and then centrifuged at 1000Ug for 10 min. The IFM and
SSM supernatants were ¢ltered through cheesecloth and centrifuged
at 10 000Ug for 10 min. IFM and SSM pellets were resuspended in
isolation medium and centrifuged at 10 000Ug for 10 min, and resus-
pended in the isolation medium. Protein concentration was deter-
mined using the bicinchoninic acid assay kit (Interchim, Montlucon,
France) with bovine serum albumin as standard.
Mitochondrial integrity was evaluated using fresh mitochondria by
measuring citrate synthase activity in the presence and absence of
detergent, following the method of Malgat et al. [20].
2.3. Measurement of proton conductance
Respiration rate and membrane potential were measured simulta-
neously using electrodes sensitive to oxygen and to the potential-de-
pendent probe triphenylmethylphosphonium (TPMPþ). Liver mito-
chondria (1 mg of protein/ml), IFM and SSM (0.5 mg of protein/
ml) were suspended in assay medium containing 120 mM KCl,
5 mM KH2PO4, 1 mM EGTA, 2 mM MgCl2, 0.3% bovine serum
albumin (w/v) and 3 mM HEPES, pH 7.4, and supplemented with
5 WM rotenone, 1 Wg/ml oligomycin, and 80 ng/ml nigericin. The
TPMP electrode was calibrated by sequential 1 WM additions up to
4 WM TPMPþ, then 4 mM succinate was added to start the reaction.
Respiration and membrane potential were progressively inhibited
through successive steady states induced by additions of malonate.
After each run, 2 WM carbonyl cyanide-p-tri£uoromethoxyphenylhy-
drazone was added to dissipate the membrane potential and release all
TPMP back into the medium for baseline correction. Membrane po-
tentials were calculated as previously described by Brand [21], assum-
ing a TPMP binding correction of 0.42 (Wl/mg protein)31 for liver
mitochondria and 0.35 (Wl/mg protein)31 for skeletal muscle mito-
chondria [22]. For the interpretation of our results, we will assume
that there was no redox slip in the mitochondrial electron transport
chain under any of the experimental conditions that we have exam-
ined, keeping in mind that if a slip in the proton pumps did occur,
then our results remain valid but their underlying mechanism might
contain an element due to slip.
2.4. Statistical analysis
Values are presented as meansSS.E.M. The statistical signi¢cance
of observed variations were assessed using one-way analysis of var-
iance. Di¡erences between means were subsequently tested by
Sche¡e¤’s F-test. Statistical signi¢cance was recognized at P6 0.05.
3. Results
3.1. Body weight, food intake and tissue mass (Table 1)
Rats treated with dexamethasone consumed less food and
weighed less than control rats. Treated rats also weighed less
than pair-fed animals though their food intake was similar.
Five days of dexamethasone injection resulted in a signi¢cant
increase in both the liver mass (+42%) and the liver to body
weight ratio (+65%). The wet weight of gastrocnemius muscle
decreased 20% after 5 days of treatment, but it remained un-
a¡ected relative to body weight (g/100 g body weight), indi-
cating that muscle weight loss paralleled body weight loss
(Table 1).
3.2. Proton leak kinetics
Fig. 1 shows the dependence of proton leak rate on mito-
chondrial membrane potential for liver and gastrocnemius
muscle mitochondrial preparations from dexamethasone-
treated, pair-fed and control rats. Liver mitochondria from
dexamethasone-treated rats displayed a higher rate of proton
leak than control and pair-fed mitochondria at any membrane
potential greater than 150 mV approximately (Fig. 1A). The
basal proton conductance of liver mitochondria calculated at
177 mV, the highest common membrane potential, was sig-
ni¢cantly increased by 40 and 37% in dexamethasone-treated
rats (124S 3 nmol Hþ/min/mg protein/mV) as compared with
control (89S 3 nmol Hþ/min/mg protein/mV) and pair-fed
(91S 8 nmol Hþ/min/mg protein/mV) animals, respectively.
To assess whether the aforementioned di¡erences were due
to damage in dexamethasone liver mitochondria, the percent-
age of broken mitochondria from each experimental group
was evaluated using fresh mitochondria. From the ratio of
the citrate synthase activities with or without Triton
(Table 2), we calculated that there was 3^4% more damage
Table 1
E¡ect of dexamethasone administration on body weight, food intake, liver and gastrocnemius masses
Control Pair-fed Dexamethasone
Body weight g 356S 12 337S 8 295S7*2
Food intake g/day 39.4S 1.5 28.1S 1.4* 29.0S 1.4*
g/100 g/day 10.6S 0.2 7.7 S 0.4* 8.3S 0.3*
Liver mass g 10.4S 0.4 9.4 S 0.2* 14.0S 0.5*2
g/100 g 2.93S 0.06 2.80S 0.03 4.74S0.12*2
Gastrocnemius mass g 4.1 S 0.1 3.9 S 0.1 3.2S 0.1*2
g/100 g 1.14S 0.02 1.15S 0.02 1.10S0.02
Rats were injected with dexamethasone i.p. (for 5 days) at a dose of 1.5 mg/kg/day. Control rats were fed ad libitum and received no treat-
ment. Pair-fed rats were provided with the same amount of food as dexamethasone-injected rats and were given an equal volume of saline. Re-
sults are the meanSS.E.M. of 12 rats. Symbols indicate signi¢cant di¡erences (P6 0.05) as follows: *di¡erence from control group; 2di¡erence
from pair-fed group.
FEBS 27151 9-4-03
D. Roussel et al./FEBS Letters 541 (2003) 75^7976
to the mitochondria in the dexamethasone group than in the
two control groups. We concluded that this slight di¡erence in
mitochondrial breakage cannot be responsible for the large
di¡erences in proton conductance described herein.
Contrary to liver, IFM isolated from dexamethasone gas-
trocnemius muscle had proton leak kinetics that may have
di¡ered from control mitochondria (Fig. 1B), whereas none
of the SSM proton leak kinetics were distinguishable between
the experimental groups (Fig. 1C). Table 3 shows the proton
conductance calculated in each experimental condition at 162
mV, the highest common membrane potential in all of the
mitochondrial preparations. In control rats, muscle mitochon-
dria exhibited a basal proton conductance four times greater
than that of liver mitochondria, with no di¡erence observed
between IFM and SSM populations. In the liver, the e¡ect of
dexamethasone on the basal proton conductance was less pro-
nounced (+30%) at 162 mV, but it is still considered statisti-
cally signi¢cant. In the muscle, there was a tendency for pro-
ton conductance to decrease following dexamethasone
treatment in IFM (P=0.095 vs. control group), whereas it
remained unchanged in SSM. Interestingly, as a result of
this non-signi¢cant decrease in IFM proton conductance,
SSM proton conductance became signi¢cantly higher than
that of IFM within the dexamethasone group.
4. Discussion
The observation that dexamethasone decreases food intake
is in line with the previously reported anorexic e¡ect of glu-
cocorticoid infusion in rats [8,23]. As far as our experimental
design is concerned, it has been found that a daily injection of
dexamethasone at 1.50 mg/kg body weight induced a transi-
tory anorexia in adult rat from day 2 to day 6, with food
intake returning to the pre-treatment values by day 7 [8].
The fact that dexamethasone-treated animals had the same
average food intake (g/day or g/100 g body weight/day) as
pair-fed animals but weighed less (Table 1) clearly indicates
that a negative energy balance was more pronounced in rats
given glucocorticoid. Since chronic injection of dexametha-
sone upregulates intestinal nutrient transport [24], it is sug-
gested that the whole body energy expenditure of the dexa-
methasone-injected rats was increased. Although we did not
measure energy expenditure, there is evidence that the admin-
istration of glucocorticoids is indeed associated with an in-
crease in resting energy expenditure in rats [23,25], as well
as in humans [26,27]. Considering the various organs that
contribute to oxygen consumption in the adult rat, liver and
skeletal muscle contribute a much larger fraction of the total
resting metabolic rate than others. Therefore, although liver
mass represents less than 5% of body weight, its metabolic
activity has been estimated to account for 20% of energy ex-
penditure in the rat. In contrast, skeletal muscles do make a
signi¢cant 30% contribution by virtue of their size, even
though their speci¢c metabolic rate is relatively low during
resting metabolism. Five days of dexamethasone injections
resulted in a signi¢cant 65% increase in the liver to body
weight ratio, and no alteration in the gastrocnemius to body
weight ratio. Such e¡ects of glucocorticoids on these organs
are consistent with previously published data [8,28,29]. Ac-
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Fig. 1. Kinetics of proton leak of liver and skeletal muscle mito-
chondria from dexamethasone-treated (¢lled symbols), pair-fed (gray
symbols) and control rats (open symbols). A: Liver mitochondria.
B: IFM. C: SSM. Values are meansSS.E.M. of ¢ve to six di¡erent
mitochondrial preparations.
Table 2
Citrate synthase activity of liver mitochondria measured in the absence (intact) and presence (broken) of Triton
Control Pair-fed Dexamethasone
Intact 0.027S 0.004 0.020S 0.002 0.030S 0.008
Broken 0.511S 0.037 0.460S 0.026 0.357S 0.034*2
Breakage (%) 5.7 S 1.1 4.2S 0.2 8.6S 1.9
Citrate synthase activity is expressed in U/mg protein. Values are meanSS.E.M. of seven di¡erent mitochondrial preparations in each group.
Symbols indicate signi¢cant di¡erences (P6 0.05) as follows: *di¡erence from control group; 2di¡erence from pair-fed group.
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cording to the relative tissue contributions to the standard
metabolic rate as given above, the liver weight gain elicited
by the chronic injection of dexamethasone will therefore result
in up to a 13% increase in whole body energy expenditure in
treated rats as compared with control animals of the same
body weight.
The contribution of cellular energy processes to the stan-
dard metabolic rate can be quanti¢ed in terms of coupling to
ATP turnover or uncoupling. On the one hand, chronic in-
jection of glucocorticoid hormones has been well character-
ized to induce several ATP-demanding pathways, such as the
ubiquitin-proteasome proteolysis [5,6] and glutamine synthesis
[7,8] in skeletal muscles, and gluconeogenesis in the liver and
kidney [3,4], which may play an important role in increasing
whole body energy expenditure. On the other hand, the mi-
tochondrial proton leak is an important contributor to skel-
etal muscle and liver metabolic rates, even under conditions in
which ATP-consuming pathways have been stimulated [30].
Therefore, it is worth asking whether mitochondrial proton
leak may play a role in the hypermetabolic state that is seen
with increased levels of circulating glucocorticoid hormones.
On the whole, it appears that dexamethasone treatment spe-
ci¢cally a¡ects liver mitochondrial proton conductance, which
was increased by 30^40% in the present study. If we assume
that the energy consumed by proton leak represents approx-
imately 22% of the energy budget of stimulated liver cells
[30], and given the value of the contribution of the liver to
the standard metabolic rate in rats given dexamethasone
(V33%), we can thus estimate that dexamethasone-enhanced
mitochondrial proton leak in this organ can induce up to a
3% increase in whole body energy expenditure in treated ani-
mals. This stimulation of proton leak rate by dexamethasone
could in turn account for approximately 15% of the aug-
mented whole body oxygen consumption of rats given gluco-
corticoids [23,25]. Finally, it must be stressed that glucocorti-
coids have been previously shown to enhance mitochondrial
proton conductance in thymocytes [12]. With this in mind, we
cannot completely disregard the fact that other organs such as
the gastrointestinal tract, kidney or brain, which have similar
mitochondrial proton leak characteristics to those found in
liver mitochondria [22], could also be a¡ected by glucocorti-
coids. Although the e¡ect of glucocorticoid treatment on the
kinetics of mitochondrial proton leak of those organs is cur-
rently not known, this hypothesis deserves further attention.
In conclusion, although dexamethasone treatment speci¢-
cally increased the rate of proton leak in liver mitochondria
by 40%, this energy-consuming mechanism would only have a
modest impact on whole body energy expenditure in the rat.
Our results therefore suggest that a glucocorticoid-induced
hypermetabolic state would be mainly achieved by increasing
the rates of several cellular ATP-demanding processes in con-
cert. However, it is likely that the substantial increase in the
rate of proton leak in liver mitochondria following glucocor-
ticoid injection might serve other functions in this organ, such
as a reduction in harmful free radical production [31], control
of the e¡ective P/O ratio of oxidative phosphorylation [32] or
regulation of carbon £uxes by keeping the mitochondrial
NADþ/NADH ratio su⁄ciently high to allow the £ow of
carbon to continue [33]. In light of the above results, the latter
hypothesis is of particular interest. Indeed, there is evidence to
suggest that glucocorticoids did cause the liver mitochondrial
NADþ/NADH redox couple to rise [34,35]. Therefore, it is
tempting to propose that the observed increase in the rate of
proton leak in liver mitochondria could be responsible for the
more oxidized mitochondrial redox state seen with glucocorti-
coids. However, this hypothesis needs further experimental
testing in order to be clearly demonstrated.
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